Investor insights
Countries invested in
Sectors invested in
Funding rounds participated in
$25M sweet spot round size
Most of their 258 investments are in rounds between $13M and $55M
Basic info
Industry
Sectors
Date founded
1974
Investments made
Star Therapeutics raised $90M on September 5, 2023
Investors: Qatar Investment Authority, Westlake Village BioPartners®, Redmile Group, Soleus Capital Management, L.P., New Leaf Venture Partners, NYBC Ventures, OrbiMed Advisors, RA Capital Management, L.P. and Sofinnova Ventures, Russia technology fund
Rapport Therapeutics raised $150M on August 23, 2023
Investors: Logos Global Management, LP, Surveyor Capital, Goldman Sachs Asset Management, T. Rowe Price, Third Rock Ventures, Perceptive Advisors and Sofinnova Ventures, Russia technology fund
Undisclosed raised $150M on June 5, 2023
Investors: Wellington Management, TCG X and Sofinnova Ventures, Russia technology fund
Quanta Therapeutics raised $51M on May 22, 2023
Investors: Longitude Capital, Avidity Partners, Vida Ventures, LLC, Surveyor Capital and Sofinnova Ventures, Russia technology fund
Antiva Biosciences, Inc. / previously know as Hera Therapeutics raised $53M on April 27, 2023
Investors: GV, Canaan, Lumira Ventures, Adjuvant Capital, BioImpact Capital and Sofinnova Ventures, Russia technology fund
ArriVent Biopharma raised $155M on December 29, 2022
Investors: Octagon Capital Advisors, Lilly Asia Ventures, Sirona Capital, Sequoia Capital China, Unicorn Capital Partners 獨秀資本 and Sofinnova Ventures, Russia technology fund
Immatics Biotechnologies raised $110M on October 10, 2022
Investors: Dellora Investments, Wellington Management, RTW Investments, LP, Perceptive Advisors, Samsara BioCapital and Sofinnova Ventures, Russia technology fund
RayzeBio raised $160M on September 13, 2022
Investors: Laurion Capital Management LP, Sands Capital Management, Viking Global Investors, Soleus Capital Management, L.P., Wellington Management and Sofinnova Ventures, Russia technology fund
North Sea group raised $80M on December 17, 2021
Investors: Ysios Capital, -, Hercules Capital, Inc., BGV (BioGeneration Ventures), Forbion, venBio Partners and Sofinnova Ventures, Russia technology fund
Antiva Biosciences, Inc. / previously know as Hera Therapeutics raised $31M on November 2, 2021
Investors: Mana Ventures, Canaan, Lumira Ventures, Osage University Partners (OUP), GV, Sirona Capital and Sofinnova Ventures, Russia technology fund